Lifeng Luo, Ph.D.
Affiliations: | 2003 | Rutgers University, New Brunswick, New Brunswick, NJ, United States |
Area:
Environmental Sciences, HydrologyGoogle:
"Lifeng Luo"Parents
Sign in to add mentorAlan Robock | grad student | 2003 | Rutgers, New Brunswick | |
(Evaluation of land surface models using ground-based point -scale measurements.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Wu HY, Luo LF, Wei F, et al. (2023) Comprehensive clinicopathological significance and putative transcriptional mechanisms of Forkhead box M1 factor in hepatocellular carcinoma. World Journal of Surgical Oncology. 21: 366 |
Tao F, Ye Q, Chen Y, et al. (2023) Antigen-loaded flagellate bacteria for enhanced adaptive immune response by intradermal injection. Journal of Controlled Release : Official Journal of the Controlled Release Society |
Luo L, Zhang B, Tao F, et al. (2023) Perfluorotributylamine-Loaded Albumin Nanoparticles Downregulate Platelet-Derived TGFβ to Inhibit Tumor Metastasis. Acs Nano. 17: 15388-15400 |
Luo L, Chen Z, Gong T, et al. (2023) Cytosolic perfluorocarbon delivery to platelets via albumin for antithrombotic therapy. Journal of Controlled Release : Official Journal of the Controlled Release Society |
Bao Z, Luo L, Xu T, et al. (2022) Risk factors and prognostic role of renal adverse event in patients receiving immune checkpoint inhibitor therapy: analysis of data from a retrospective cohort study. Annals of Translational Medicine. 10: 967 |
Yang J, Zeng R, Zhou J, et al. (2022) Efficacy, prognosis and safety analysis of anti-PD-1/PD-L1 inhibitor rechallenge in advanced lung cancer patients: a cohort study. Translational Lung Cancer Research. 11: 1038-1050 |
Wang C, Wang H, Luo L, et al. (2022) Scintillator-based radiocatalytic superoxide radical production for long-term tumor DNA damage. Biomaterials Science |
Zeng R, Luo L, Sun X, et al. (2021) EGFR/BRAF/MEK co-inhibition for EGFR-mutated lung adenocarcinoma patients with an acquired BRAF mutation: a case report and review of literature. Cancer Drug Resistance (Alhambra, Calif.). 4: 1019-1027 |
Zeng R, Liu F, Fang C, et al. (2021) PIV and PILE Score at Baseline Predict Clinical Outcome of Anti-PD-1/PD-L1 Inhibitor Combined With Chemotherapy in Extensive-Stage Small Cell Lung Cancer Patients. Frontiers in Immunology. 12: 724443 |
Hatami Bahman Beiglou P, Luo L, Tan PN, et al. (2021) Automated Analysis of the US Drought Monitor Maps With Machine Learning and Multiple Drought Indicators. Frontiers in Big Data. 4: 750536 |